What is the recommended protocol for infusing albumin (human albumin) during large volume paracentesis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Albumin Infusion Protocol for Large Volume Paracentesis

For large volume paracentesis (>5 liters), albumin should be infused after the procedure is completed at a dose of 8 g albumin per liter of ascites removed, using 20% or 25% albumin solution. 1, 2

Dosing Guidelines

  • For paracentesis >5 liters: Administer 8 g albumin per liter of ascites removed (e.g., 100 ml of 20% albumin per 3 liters of ascites) 1
  • For paracentesis <5 liters: Albumin replacement is generally not required for uncomplicated ascites; synthetic plasma expanders can be used instead 1
  • For high-risk patients (those with acute-on-chronic liver failure or high risk of post-paracentesis acute kidney injury): Consider albumin replacement at 8 g/L even for volumes <5 liters 1, 2

Administration Protocol

  • Use 20% or 25% albumin solution (25% solution contains 25 g albumin per 100 mL) 2
  • Infuse albumin after paracentesis is completed, not during the procedure 1
  • Complete the paracentesis in a single session, draining ascites to dryness as rapidly as possible over 1-4 hours 1
  • Perform the entire procedure under strict sterile conditions 1

Clinical Rationale

  • Albumin replacement prevents post-paracentesis circulatory dysfunction (PICD), which can lead to serious complications including: 2

    • Renal impairment and hepatorenal syndrome
    • Dilutional hyponatremia
    • Hepatic encephalopathy
    • Increased mortality
  • Studies show significantly higher rates of renal impairment, hyponatremia, and activation of the renin-angiotensin-aldosterone system in patients not treated with albumin after large volume paracentesis 1

Special Considerations

  • For patients with spontaneous bacterial peritonitis (SBP), use a different dosing regimen: 1.5 g albumin/kg within 6 hours of diagnosis, followed by 1 g/kg on day 3 1, 2
  • The risk of PICD increases with >8 L of fluid evacuated in a single session 2
  • While some studies have investigated using half-doses of albumin (4 g/L), current guidelines still strongly recommend the standard 8 g/L dose 3, 1
  • Synthetic plasma expanders (dextran, gelatin, hydroxyethyl starch) are less effective than albumin in preventing PICD and hyponatremia 4, 1

Procedure Technique

  • Insert the needle into the left (preferably) or right lower abdominal quadrant using the "Z" track technique 1
  • Use a cannula with multiple side perforations to prevent blockage by bowel wall 1
  • After paracentesis, have the patient lie on the opposite side for two hours if there is leakage of remaining ascitic fluid 1
  • Consider placing a purse-string suture around the drainage site to minimize risk of ascitic fluid leakage 1

Monitoring

  • Monitor for signs of renal impairment, hyponatremia, and hypotension following the procedure 5
  • The drain should not be left in overnight 1
  • Ultrasound guidance should be considered when available to reduce the risk of adverse events 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Albumin Replacement Formula for Paracentesis in Ascites

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Prevention of paracentesis-induced circulatory dysfunction in cirrhosis: standard vs half albumin doses. A prospective, randomized, unblinded pilot study.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2011

Research

Standardizing the Use of Albumin in Large Volume Paracentesis.

Journal of pharmacy practice, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.